Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Severe , such as hyperinfection syndrome, carries a high mortality risk. Even with appropriate treatment, patients may experience infectious complications and failure of therapy. Currently, there are no Food and Drug Administration-approved parenteral therapies available for treatment in patients who develop gastrointestinal complications from hyperinfection, including small bowel obstruction. A veterinary form of ivermectin is available as a subcutaneous injection, although current literature in humans is limited. We report on the successful treatment of two surviving immunocompromised patients with hyperinfection syndrome after prompt recognition and initiation of veterinary subcutaneous ivermectin therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990086 | PMC |
| http://dx.doi.org/10.1136/bcr-2017-223138 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Impact of Ivermectin on Immune Response and Wound Healing in a Mouse Model Infected With .
J Trop Med
August 2025
Department of Parasitology, School of Paramedicine, Ilam University of Medical Sciences, Ilam, Iran.
Understanding the immune pathogenesis mechanisms of leishmaniasis is crucial for developing effective therapeutic interventions. In this study, we investigated the effect of ivermectin (IVE) on the expression of transcription factors GATA-binding protein 3 (GATA-3), T-bet, and ROR-γt as well as wound healing Leishmania infection. Leishmania promastigotes were subcutaneously inoculated into the tail base of BALB/c mice ( = 10 per group) who later received phosphate-buffered saline (PBS), IVE, Glucantime, or a combination of IVE and Glucantime as soon as wounds developed, approximately three weeks' postinfection.
View Article and Find Full Text PDFStrongyloides Hyperinfection Treated with Subcutaneous Ivermectin in a Patient with an Inborn Error of Immunity.
Am J Trop Med Hyg
August 2025
Department of Infectious Diseases, Beaumont Hospital, Dublin, Ireland.
Strongyloides hyperinfection can be challenging to diagnose and treat. Although it is typically described in cases of secondary immunodeficiency, it has not previously been reported in a case of inborn error of immunity. Diagnosis via microscopy can be time-consuming and challenging, and serology results may be negative in the setting of hypogammaglobulinemia.
View Article and Find Full Text PDFStrongyloidiasis in a heart transplant recipient: Exploring the use of veterinary-formulated subcutaneous ivermectin and a review of the literature.
IDCases
August 2025
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA.
can complete its entire life cycle within the human host, allowing infections to persist for years. While it may cause chronic, often asymptomatic infection in immunocompetent individuals, it can lead to life-threatening hyperinfection syndrome or disseminated disease in those who are immunocompromised. We report a case of hyperinfection syndrome in a heart transplant recipient who had tested negative on conventional serologic screening as part of his pretransplant workup three years prior to transplantation.
View Article and Find Full Text PDFStrongyloidiasis (or anguillulosis) is helminthosis caused by Strongyloides stercoralis found mostly in (sub)tropical areas and sometimes in temperate settings. We report a case of strongyloidiasis hyperinfection, diagnosed on a BALF in a 46-year-old woman of senegalese origin with no recent travel history. The patient initially presented to the emergency department with worsening chronic lower back pain, asthenia and a 10-day history of general deterioration.
View Article and Find Full Text PDFExperimental study on the effect of Ivermectin on cattle dung faunas in Eastern Ethiopia.
PLoS One
April 2025
School of Veterinary Medicine, Woldia University, Woldia, Ethiopia.
An experimental investigation was conducted from December 2023 to June 2024 at the beef farm of Haramaya University. The bulls were divided into two groups: one group received ivermectin treatment, while the other acted as a control. The SUMIVER brand of ivermectin was administered subcutaneously at 1 ml per 50 kg of body weight.
View Article and Find Full Text PDF